{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:10:47Z","timestamp":1780416647151,"version":"3.54.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.msard.2025.106939","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T07:56:22Z","timestamp":1766130982000},"page":"106939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Is newly diagnosed multiple sclerosis a medical emergency?"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0104-8462","authenticated-orcid":false,"given":"H","family":"El Mouhajir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Alrashed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Schmierer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106939_bib0001","unstructured":"A different path: Rethinking MS hospital care [WWW Document], n.d. . Multiple Sclerosis Society UK. URL https:\/\/www.mssociety.org.uk\/about-us\/how-we-work\/our-evidence\/different-path-rethinking-ms-hospital-care (accessed 11.28.25b)."},{"key":"10.1016\/j.msard.2025.106939_bib0002","article-title":"84 Are concerns over switching from Tysabri to Tyruko justified?","volume":"96","author":"Alrashed","year":"2025","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106939_bib0003","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.msard.2013.09.007","article-title":"Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosis","volume":"3","author":"Altmann","year":"2014","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106939_bib0004","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.msard.2025.106939_bib0005","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/jnnp-2017-317509","article-title":"Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?","volume":"89","author":"Cerqueira","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106939_bib0006","article-title":"Towards primary prevention of multiple sclerosis","author":"Dobson","year":"2025","journal-title":"Nat. Rev. Neurol."},{"issue":"Pt 3","key":"10.1016\/j.msard.2025.106939_bib0007","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/brain\/120.3.393","article-title":"Axonal damage in acute multiple sclerosis lesions","volume":"120","author":"Ferguson","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106939_bib0008","article-title":"MS Care: integrating Advanced Therapies and Holistic Management","volume":"14","author":"Giovannoni","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2025.106939_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(20)30067-3","article-title":"Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study","author":"He","year":"2020","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.msard.2025.106939_bib0010","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1177\/1352458518809326","article-title":"International consensus on quality standards for brain health-focused care in multiple sclerosis","volume":"25","author":"Hobart","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106939_bib0011","doi-asserted-by":"crossref","DOI":"10.1101\/2025.02.05.25320428","article-title":"Real-world experience with switching from originator to biosimilar natalizumab","author":"H\u00f8gest\u00f8l","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106939_bib0012","doi-asserted-by":"crossref","unstructured":"J. Coles, A., 2017. Alemtuzumab durably improves clinical outcomes in patients with active RRMS in the absence of continuous treatment: 7-year follow-up of CARE-MS-I patients (TOPAZ study). https:\/\/doi.org\/10.26226\/morressier.59a3edacd462b8028d895453.","DOI":"10.26226\/morressier.59a3edacd462b8028d895453"},{"key":"10.1016\/j.msard.2025.106939_bib0013","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.28271","article-title":"Risk factors and time to clinical symptoms of multiple sclerosis among patients with radiologically isolated syndrome","volume":"4","author":"Lebrun-Fr\u00e9nay","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.msard.2025.106939_bib0014","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1007\/s00415-021-10935-6","article-title":"Fitness, physical activity, and exercise in multiple sclerosis: a systematic review on current evidence for interactions with disease activity and progression","volume":"269","author":"Proschinger","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106939_bib0015","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/brain\/awab385","article-title":"The impact of smoking cessation on multiple sclerosis disease progression","volume":"145","author":"Rodgers","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106939_bib0016","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1136\/jnnp-2022-abn2.196","article-title":"152 AttackMS natalizumab for the treatment of people with inflammatory demyeli- nation suggestive of multiple sclerosis","volume":"93","author":"Schmierer","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106939_bib0017","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ana.20202","article-title":"Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain","volume":"56","author":"Schmierer","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2025.106939_bib0018","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/WCO.0000000000000937","article-title":"Highly effective disease-modifying treatment as initial MS therapy","volume":"34","author":"Schmierer","year":"2021","journal-title":"Curr. Opin. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825006777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825006777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:54:39Z","timestamp":1780415679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825006777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":18,"alternative-id":["S2211034825006777"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106939","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is newly diagnosed multiple sclerosis a medical emergency?","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106939","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106939"}}